SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0001213900-21-054182
Filing Date
2021-10-22
Accepted
2021-10-22 16:02:02
Documents
7

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea149233-f1_nlspharma.htm F-1 300700
2 OPINION OF WENGER & VIELI AG, SWISS COUNSEL TO NLS PHARMACEUTICS LTD ea149233ex5-1_nls.htm EX-5.1 30850
3 CONSENT OF PRICEWATERHOUSECOOPERS AG ea149233ex23-1_nls.htm EX-23.1 5418
4 GRAPHIC image_001.jpg GRAPHIC 14048
5 GRAPHIC image_002.jpg GRAPHIC 14048
6 GRAPHIC ex5-1_001.jpg GRAPHIC 3286
7 GRAPHIC ex23-1_001.jpg GRAPHIC 2556
  Complete submission text file 0001213900-21-054182.txt   385188
Mailing Address ALTER POSTPLATZ 2 STANS V8 CH-6370
Business Address ALTER POSTPLATZ 2 STANS V8 CH-6370 41-41-618-80-00
NLS Pharmaceutics Ltd. (Filer) CIK: 0001783036 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: F-1 | Act: 33 | File No.: 333-260435 | Film No.: 211340541
SIC: 2834 Pharmaceutical Preparations